<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04321083</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC18AD078918CTIL</org_study_id>
    <nct_id>NCT04321083</nct_id>
  </id_info>
  <brief_title>Measurement of Cerebral rSO2 Levels During Sleep in Children With Suspected Obstructive Sleep Apnea</brief_title>
  <acronym>O2SLEEP</acronym>
  <official_title>Measurement of Cerebral rSO2 Levels During Sleep in Children With Suspected Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_ppsd>Yes</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The gold standard of obstructive sleep apnea (OSA) is (PSG)POLYSOMNOGRAPHY. During the
      examination, the patient is monitored by saturation, EEG and other measurements.

      Near infrared spectroscopy is an uprising technology allowing non invasive measurement of the
      frontal lobe oxygenation. It is painless and does not have side effects. We believe that
      brain saturation will be more accurate then peripheral pulse oximeter and will be better
      correlated with the clinical presentation of OSA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      a prospective cohort study study group - pediatric population referred to PSG in Dana Duek
      Hospital. After informed consent received from the parents, the parents will fulfill
      &quot;Connors&quot; (age 6 +) &amp; &quot;Brief&quot; (age 4-6) questionnaires.

      During the PSG, the brain saturation will be monitored by INVOS(TM) Medtronic device. They
      will be monitored &amp; synchronized with the peripheral saturation documented performed as part
      of the PSG examination.

      The brain saturation &amp; peripheral saturation levels will be compared and both will be
      correlated to the questionnaires &amp; AHI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 11, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>INVOS Medtronic device will be applied simultaneously with sleep lab monitoring</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between brain o2 levels to peripheral measurements</measure>
    <time_frame>procedure (during the examination PGS)</time_frame>
    <description>correlation between brain o2 levels to peripheral measurements</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Pediatric Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>O2 brain (central) measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>INVOS will be applied simultaneously for monitoring along with the regular polysomnography (sleep lab) workup</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>INVOS</intervention_name>
    <description>INVOS monitoring brain o2 saturation</description>
    <arm_group_label>O2 brain (central) measurement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  4-16 y/o pediatric population referred for PSG in Dana Hospital

        Exclusion Criteria:

          -  down synd.

          -  craniofacial malformation

          -  PPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ari Derowe, prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana Duek pediatric hospital, TASMC, TA, ISRAEL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ari DeRowe, prof</last_name>
    <phone>05246266357</phone>
    <email>arid@tlvmc.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dana Duek pediatric hospital TASMC</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ari DeRowe, Prof</last_name>
      <phone>0524266357</phone>
      <email>AriD@tlvmc.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

